CANC
Tema Oncology ETF·NASDAQ
--
--(--)
--
--(--)
Tema Oncology ETF Fundamentals
Assets Under Management
159.07MUSD
Fund Flows (1Y)
66.45MUSD
Dividend Yield (TTM)
0.06%
Discount/Premium to NAV
0.09%
Shares Outstanding
4.57M
Expense Ratio
0.75%
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -6.58% | -1.92% | -0.15% | +38.46% | +38.93% | +38.93% |
NAV Total Return | -7.40% | -1.51% | +0.81% | +40.32% | +0.02% | +0.02% |
Ratings
Aime Ratings
No data is currently available
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
79.87%
16.13%
4%
Category
Ratio
North America
79.87%
Europe
16.13%
Asia
4.00%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Growth
Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.
Top 10 Holdings
Symbol
Ratio
RVMD
Revolution Medicines
6.04%
NOVARTIS AG
4.56%
ASTRAZENECA PLC
4.50%
ROCHE HOLDING AG
4.27%
LLY
Eli Lilly
4.16%
BMY
Bristol-Myers Squibb
3.65%
BBIO
BridgeBio Pharma
3.61%
MRK
Merck
3.42%
COGT
Cogent Biosciences
3.27%
NUVL
Nuvalent
3.18%
Top 10 Weight 40.66%
53 Total Holdings
Is SPY better than CANC?
Dividends
Dividend Payout History
Ex-Div Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-12-10 | 2025-12-10 | 2025-12-11 | 0.020 |
| 2024-12-11 | 2024-12-11 | 2024-12-12 | 0.500 |
| 2023-12-13 | 2023-12-14 | 2023-12-15 | 0.015 |
How Much Does CANC Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy CANC?
Fund Flows
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
